{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:37Z","timestamp":1792025197052,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":2149,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1186\/s13613-020-00685-5","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T06:05:54Z","timestamp":1591596354000},"page":"75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Amikacin pharmacokinetic\/pharmacodynamic in intensive care unit: a prospective database"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-1896","authenticated-orcid":false,"given":"Elsa","family":"Logre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Enser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Claudinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Grall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Mentec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Montravers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Pajot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/s13613-020-00685-5_bb0010","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"10.1186\/s13613-020-00685-5_bb0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-020-00685-5_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1186\/s13613-020-00685-5_bb0025","unstructured":"EUCAST. Aminoglycosides: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_10.0_Breakpoint_Tables.pdf.n.d."},{"key":"10.1186\/s13613-020-00685-5_bb0030","unstructured":"ANSM. Bon usage des aminosides administr\u00e9s par voie injectable: gentamicine, tobramycine, netilmicine, amikacine \u2013 Mise au point 2011."},{"key":"10.1186\/s13613-020-00685-5_bb0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijantimicag.2011.03.022","article-title":"Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity","volume":"38","author":"G\u00e1lvez","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/s13613-020-00685-5_bb0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00134-014-3276-x","article-title":"Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25?mg\/kg total body weight regimen","volume":"40","author":"de Montmollin","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-020-00685-5_bb0045","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc8945","article-title":"Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"10.1186\/s13613-020-00685-5_bb0050","unstructured":"D\u00e9cret n\u00b0 2016-1537 du 16 novembre 2016 relatif aux recherches impliquant la personne humaine. Disponible sur https:\/\/www.legifrance.gouv.fr\/eli\/decret\/2016\/1\/16\/AFSP1621392D\/jo\/texte Alias: https:\/\/www.legifrance.gouv.fr\/eli\/decret\/2016\/11\/16\/2016-1537\/jo\/texte.n.d."},{"key":"10.1186\/s13613-020-00685-5_bb0055","unstructured":"CDC. CDC\/NHSN Surveillance Definitions for Specific Types of Infections. Available of https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/17pscnosinfdef_current.pdf.n.d."},{"key":"10.1186\/s13613-020-00685-5_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00007691-199504000-00005","article-title":"Multicenter quality control study of amikacin assay for monitoring once-daily dosing regimens","volume":"17","author":"Blaser","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1186\/s13613-020-00685-5_bb0065","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new simplified acute physiology score (SAPS II) based on a European\/North American multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"10.1186\/s13613-020-00685-5_bb0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-020-00685-5_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.12374","article-title":"Determinants of amikacin first peak concentration in critically ill patients","author":"Boidin","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1186\/s13613-020-00685-5_bb0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1186\/s13613-020-00685-5_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-016-0211-z","article-title":"Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock","author":"Allou","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1186\/s13613-020-00685-5_bb0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00228-014-1766-y","article-title":"Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia","volume":"71","author":"Burdet","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1186\/s13613-020-00685-5_bb0095","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/jac\/dku569","article-title":"Impact of imipenem and amikacin pharmacokinetic\/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia","volume":"70","author":"Pajot","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-020-00685-5_bb0100","unstructured":"EUCAST. Antimicrobial wild type distributions of microorganisms. https:\/\/mic.eucast.org\/Eucast2.n.d."},{"key":"10.1186\/s13613-020-00685-5_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jac\/dkv291","article-title":"Impact of 30\u00a0mg\/kg amikacin and 8\u00a0mg\/kg gentamicin on serum concentrations in critically ill patients with severe sepsis","volume":"71","author":"Roger","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1186\/s13613-020-00685-5_bb0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijantimicag.2017.11.009","article-title":"Higher versus standard amikacin single dose in emergency department patients with severe sepsis and septic shock: a randomised controlled trial","volume":"51","author":"De Winter","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1186\/s13613-020-00685-5_bb0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/AAC.43.3.623","article-title":"Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria","volume":"43","author":"Kashuba","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1186\/s13613-020-00685-5_bb0120","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/cc12844","article-title":"Therapeutic drug monitoring of amikacin in septic patients","volume":"17","author":"Duszynska","year":"2013","journal-title":"Crit Care"},{"key":"10.1186\/s13613-020-00685-5_bb0125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","article-title":"Aminoglycosides: nephrotoxicity","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-020-00685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-020-00685-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025011069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025011069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-020-00685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:41:45Z","timestamp":1776670905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025011069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["S2110582025011069"],"URL":"https:\/\/doi.org\/10.1186\/s13613-020-00685-5","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amikacin pharmacokinetic\/pharmacodynamic in intensive care unit: a prospective database","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-020-00685-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Author(s) 2020. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"75"}}